The effects of local vanadium treatment on angiogenesis and chondrogenesis during fracture healing

Journal of Orthopaedic Research

Volumn 30, Issue 12, 2012, Pages 1971-1978

  Paglia, David N ^a   Wey, Aaron ^a   Park, Andrew G ^a   Breitbart, Eric A ^a   Mehta, Siddhant K ^a   Bogden, John D ^a   Kemp, Francis W ^a   Benevenia, Joseph ^a   O'Connor, J Patrick ^a   Lin, Sheldon S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

BB Wistar rat; bone regeneration; fracture healing; vanadium

Indexed keywords

ACETYLACETONATE VANADIUM; CD31 ANTIGEN; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CALLUS; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DOSE COMPARISON; DRUG EFFECT; FEMUR FRACTURE; FRACTURE HEALING; IMMUNOHISTOCHEMISTRY; INTRAMEDULLARY ADMINISTRATION ROUTE; LOCAL THERAPY; MALE; MINERALIZATION; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; TORQUE;

ANIMALS; BONE AND BONES; CELL PROLIFERATION; CHONDROGENESIS; FEMORAL FRACTURES; FRACTURE HEALING; HYDROXYBUTYRATES; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PENTANONES; RATS; RATS, WISTAR; REGENERATION; STRESS, MECHANICAL; TORQUE; VANADIUM;

EID: 84867874071     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22159     Document Type: Article

References (26)

1. Thrailkill KM, Lumpkin CK Jr, Bunn RC, et al. 2005. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289: E735-E745.
2. Gandhi A, Beam HA, O'Connor JP, et al. 2005. The effects of local insulin delivery on diabetic fracture healing. Bone 37: 482-490.
3. Dedania J, Borzio R, Paglia D, et al. 2011. Role of local insulin augmentation upon allograft incorporation in a rat femoral defect model. J Orthop Res 29: 92-99.
4. Stunkle G, Wray JB,. 1965. The effect of exogenous insulin on fracture healing in the intact rat. Clin Orthop Relat Res 40: 30-34.
5. Paglia D, Wey A, Vaidya S, et al. 2011. The angiogenic effects of local ultralente insulin on periosteal bone formation. Long Beach, CA: Orthopaedic Research Society.
6. Poucheret P, Verma S, Grynpas MD, McNeill JH,. 1998. Vanadium and diabetes. Mol Cell Biochem 188: 73-80.
7. Thompson KH, Lichter J, LeBel C, et al. 2009. Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem 103: 554-558.
8. Srivastava AK, Mehdi MZ,. 2005. Insulino-mimetic and anti-diabetic effects of vanadium compounds. Diabet Med 22: 2-13.
9. Mehdi MZ, Srivastava AK,. 2005. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis. Arch Biochem Biophys 440: 158-164.
10. Barrio DA, Etcheverry SB,. 2010. Potential use of vanadium compounds in therapeutics. Curr Med Chem 17: 3632-3642.
11. Engesaeter LB, Ekeland A, Langeland N,. 1978. Methods for testing the mechanical properties of the rat femur. Acta Orthop Scand 49: 512-518.
12. Matsusaki K, Nomi M, Higa M, et al. 1999. Determination of vanadium, chromium and molybdenumn by atomic absorption spectrometry using a graphite furnace coated with boron. Anal Sci 15: 145.
13. Bogden JD, Higashino H, Lavenhar MA, et al. 1982. Balance and tissue distribution of vanadium after short-term ingestion of vanadate. J Nutr 112: 2279-2285.
14. Schmidmaier G, Wildemann B, Gabelein T, et al. 2003. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand 74: 604-610.
15. Einhorn TA, Majeska RJ, Mohaideen A, et al. 2003. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am 85-A: 1425-1435.
16. Kato Y, Iwamoto M, Koike T, Suzuki F,. 1987. Effect of vanadate on cartilage-matrix proteoglycan synthesis in rabbit costal chondrocyte cultures. J Cell Biol 104: 311-319.
17. Holstein JH, Klein M, Garcia P, et al. 2008. Rapamycin affects early fracture healing in mice. Br J Pharmacol 154: 1055-1062.
18. Li M, Amizuka N, Oda K, et al. 2004. Histochemical evidence of the initial chondrogenesis and osteogenesis in the periosteum of a rib fractured model: implications of osteocyte involvement in periosteal chondrogenesis. Microsc Res Tech 64: 330-342.
19. Cortizo AM, Etcheverry SB,. 1995. Vanadium derivatives act as growth factor-mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells. Mol Cell Biochem 145: 97-102.
20. Cortizo AM, Molinuevo MS, Barrio DA, Bruzzone L,. 2006. Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action. Int J Biochem Cell Biol 38: 1171-1180.
21. Facchini DM, Yuen VG, Battell ML, et al. 2006. The effects of vanadium treatment on bone in diabetic and non-diabetic rats. Bone 38: 368-377.
22. Zhang SQ, Chen GH, Lu WL, Zhang Q,. 2007. Effects on the bones of vanadyl acetylacetonate by oral administration: a comparison study in diabetic rats. J Bone Miner Metab 25: 293-301.
23. Pei Y, Fu Q,. 2011. The effects of vanadium (V) absorbed by coprinus comatus on bone in streptozotocin-induced diabetic rats. Biol Trace Elem Res 142: 748-759.
24. Li J, Tong Q, Shi X, et al. 2005. ERKs activation and calcium signaling are both required for VEGF induction by vanadium in mouse epidermal Cl41 cells. Mol Cell Biochem 279: 25-33.
25. Zhang SQ, Zhong XY, Lu WL, et al. 2005. Pharmacodynamics and pharmacokinetics of the insulin-mimetic agent vanadyl acetylacetonate in non-diabetic and diabetic rats. J Inorg Biochem 99: 1064-1075.
26. Vardatsikos G, Mehdi MZ, Srivastava AK, et al. 2009. Bis(maltolato)- oxovanadium (IV)-induced phosphylation of PKB, GSK-3 and FOXO1 contributes to its glucoregulatory responses (Review). Int J Mol Med 24: 303-309.